Piramal Pharma Board Meeting for Q2 FY27 Results

Key Event

A meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 27th October 2026. The primary agenda for the meeting is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2026.

Trading Window Closure

In relation to the results announcement, the 'Trading Window' for dealing in the securities of the Company has been closed. The closure period is from Thursday, 1st October 2026 and will remain closed until Thursday, 29th October 2026 (both days inclusive).